The Life Sciences Innovative Manufacturing Fund (LSIMF) is making up to £520 million of grants available to support businesses investing in manufacturing projects in the UK.
The fund is designed to strengthen the UK’s health resilience and deliver economic benefits, with a particular focus on projects that contribute to pandemic preparedness.
This includes:
Production of point-of-care and high-volume diagnostics.
Diagnostics that enable preventative medicines.
Technologies that have a significant positive impact on population health, particularly through addressing chronic diseases.
The next application round will open on 3rd November 2025 and close on 28th November 2025. Eligible projects must have a total cost of at least £8 million (including capital expenditure), with government funding typically covering 10–20% of total project costs.
On 30th October, 12:00 – 13:00, members of the Office for Life Sciences’ Manufacturing Grant Delivery team will be joining ABHI members for a dedicated webinar to outline the fund, explain the application process, and answer questions from businesses interested in applying.
